Greenwich LifeSciences Inc. (GLSI) Statistics & Valuation Metrics - Stocknear

Greenwich LifeSciences In...

NASDAQ: GLSI · Real-Time Price · USD
10.93
-0.04 (-0.36%)
At close: Sep 05, 2025, 3:59 PM
10.81
-1.10%
After-hours: Sep 05, 2025, 05:17 PM EDT

Greenwich LifeSciences Statistics

Share Statistics

Greenwich LifeSciences has 13.63M shares outstanding. The number of shares has increased by 1.7% in one year.

13.63M
1.7%
1.7%
8.93%
6.11M
2,206
4.06%

Short Selling Information

The latest short interest is 1.06M, so 7.94% of the outstanding shares have been sold short.

1.06M
7.94%
16.63%
20.26

Valuation Ratios

The PE ratio is -9.26 and the forward PE ratio is -7.79. Greenwich LifeSciences's PEG ratio is -0.12.

-9.26
-7.79
0
n/a
57.68
-20.11
-0.12
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Greenwich LifeSciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.

2.62
2.62
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-3.95M
4
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -17.95% in the last 52 weeks. The beta is 3.16, so Greenwich LifeSciences's price volatility has been higher than the market average.

3.16
-17.95%
11.19
11.29
41.51
54,388

Income Statement

n/a
-3.61K
-16.01M
-15.79M
-15.79M
-15.79M
-1.21
Full Income Statement

Balance Sheet

The company has 4.09M in cash and 0 in debt, giving a net cash position of 4.09M.

4.09M
n/a
n/a
-66.15M
2.75M
1.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.27M and capital expenditures 3, giving a free cash flow of -7.27M.

-7.27M
3
-7.27M
-0.56
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

GLSI does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for GLSI is $39, which is 255.5% higher than the current price. The consensus rating is "Strong Buy".

$39
255.5%
Strong Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

8.8
2